Immunovant
IMVT
IMVT
209 hedge funds and large institutions have $2.27B invested in Immunovant in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 82 increasing their positions, 79 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
209
Holders Change
-19
Holders Change %
-8.33%
% of All Funds
3.03%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.07%
New
28
Increased
82
Reduced
79
Closed
46
Calls
$42.8M
Puts
$23.4M
Net Calls
+$19.4M
Net Calls Change
-$1.44M
Top Buyers
| 1 |
1
Viking Global Investors
Stamford,
Connecticut
|
$58.5M |
| 2 |
PBA
2
Paradigm Biocapital Advisors
New York
|
$25.8M |
| 3 |
AC
3
Armistice Capital
New York
|
$69.9M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$209M |
| 5 |
PA
5
Perceptive Advisors
New York
|
$95.7M |
